Association between botulinum toxin injection into the arm and changes in gait in adults after stroke

Movement Disorders

Volumn 20, Issue 8, 2005, Pages 1014-1020

  Hirsch, Mark A ^a,b   Westhoff, Bettina ^b   Toole, Tonya ^c   Haupenthal, Stephan ^b   Krauspe, Rüdiger ^b   Hefter, Harald ^b  

^a Charlotte Inst of Rehabilitation   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Botulinum toxin; Computerized motion analysis; Gait; Stroke

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ANKLE; ARM MOVEMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAIT DISORDER; HEMIPARESIS; HUMAN; KNEE FUNCTION; MALE; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; STROKE; THREE DIMENSIONAL IMAGING; WALKING;

ADULT; AGED; ARM; BOTULINUM TOXINS; CEREBROVASCULAR ACCIDENT; DISABILITY EVALUATION; FEMALE; GAIT; HUMANS; IMAGING, THREE-DIMENSIONAL; KNEE; LEG; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PARESIS; PILOT PROJECTS; RANGE OF MOTION, ARTICULAR; REACTION TIME;

EID: 26444511228     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20499     Document Type: Article

References (35)

1. Bowen A, Wenman R, Mickelborough J, et al. Dual-task effects of talking while walking on velocity and balance following a stroke. Age Ageing 2001;30:319-323.
2. Harris-Love ML, Forrester LW, Macko RF, et al. Hemiparetic gait parameters in over ground versus treadmill walking. Neurorehabil Neural Repair 2001;15:105-112.
3. Kerrigan DC, Frates EP, Rogan S, et al. Spastic paretic stiff-legged gait. Am J Phys Med Rehabil 1999;78:354-360.
4. Knuttson E, Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain 1997;102:405-430.
5. Bell MS, Vermeulen LC, Sperling KB. Pharmacotherapy with botulinum toxin: harnessing natures most potent neurotoxin. Pharmacotherapy 2000;20:1079-1091.
6. Backheit AMO, Sawyer J. The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiparetic gait - a pilot study. Disabil Rehabil 2002;24:519-522.
7. Gilio F, Curra A, Lorenzano C, et al. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 2000;48:20-26.
8. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin A in the treatment of upper extremity spasticity; a randomized, double blind, placebo-controlled trial. J Neurol 1996;46:1306-1310.
9. Smith SJ, Ellis E, White S, et al. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13.
10. Dengler R, Neyer U, Wohlfarth K, et al. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-378.
11. Pauri F, Boffa L, Cassetta E, et al. Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study. J Neurol Sci 2000;181:89-97.
12. Filippi GM, Errico P, Santarelli R, et al. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993;113:400-404.
13. Rosales RL, Arimura K, Takenaga S, Osame M, et al. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 1996;19:488-496.
14. Kadaba MP, Ramakrishnan HK, Wootten ME. Measurement of lower extremity kinematics during level walking. J Orthop Res 1990;8:383-392.
15. Macleod A, Morris JRW. Investigation of inherent experimental noise in kinematic experiments using superficial markers. Chicago: Biomechanics X-B Human Kinetics Publishers; 1987.
16. Evans MD, Goldie PA, Hill KD. Systematic and random error in repeated measurements of temporal and distance parameters of gait after stroke. Arch Phys Med Rehabil 1997;78:725-729.
17. Hill KD, Goldie PA, Baker PA, et al. Retest reliability of the temporal and distance characteristics of hemiplegic gait using a footswitch system. Arch Phys Med Rehabil 1994;75:577-583.
18. Westhoff B, Hirsch MA, Hefter H, Wild A, Krauspe R. Test-retest reliability of three-dimensional computerized gait analysis. Sportverletz Sportschaden 2004;2:76-79.
19. Growney E, Meglan D, Johnson M, et al. Repeated measures of adult normal walking using a video tracking system. Gait Posture 1997;6:147-162.
20. Whittle MW. Gait analysis: an introduction. Oxford: Butterworth-Heinemann; 2002.
21. Baer G, Smith M. The recovery of walking ability and subclassification of stroke. Physiother Res Int 2001;6:135-144.
22. Turnbull GI, Charteris J, Wall JC. A comparison of walking speeds between normal and hemiplegic subjects. Scand J Rehabil Med 1995;27:175-182.
23. Zamparo P, Pagliaro P, The energy cost of level walking before and after hydro-kinesi therapy in patients with spastic paresis. Scand J Med Sci Sports 1998;8:222-228.
24. Pagliaro P, Zamparo P. Qualitative evaluation of the stretch reflex before and after hydro- kinesi therapy in patients affected by spastic paresis. J Electromyogr Kinesiol 1999;9:141-148.
25. Ansved T, Odergren T, Borg K. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia. Neurology 1997;48:1440-1442.
26. Garner CG, Straube A, Witt TN, et al. Time course of distant effects of local injection of botulinum toxin. Mov Disord 1993;8: 33-37.
27. Girlanda P, Vita G, Nicolosi C, et al. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992;55:844-845.
28. Lange DJ, Brin MF, Warner CL, et al. Distant effects of local injection of botulinum toxin. Muscle Nerve 1987;10:552-555.
29. Lange DJ, Brin MF, Fahn S, Lovelace RE et al. Distant effects of locally injected botulinum toxin: incidence and course. Adv Neurol 1988;50:609-613.
30. Lange DJ, Rubin M, Greene PE, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 1991;14:672-675.
31. Priori A, Berardelli A, Mercuri B, et al. Physiological effects produced by botulinum toxin treatment of upper limb dystonia: changes in reciprocal inhibition between forearm muscles. Brain 1995;118:801-807.
32. Wiegand H, Erdmann G, Wellhoener HH. 125-I labeled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976;292:161-165.
33. Modugno N, Priori A, Berardelli A, et al. Botolinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor. Muscle Nerve 1998;12:1701-1705.
34. Giladi N. Brainstem trigeminal and auditory evoked potentials in patients with craniocervical dystonia. Neurology 1994;2(Suppl.): A214.
35. Byrnes ML, Thickbroom GW, Wilson SA, et al. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection. Brain 1998;121:977-988.